(888) 352-RUSH for help arranging an appointment.
Faculty Rank: Professor
Medical or Graduate Education:
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center - Psychiatry
Transcranial magnetic stimulation
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA CNS Spectr 2013 Jul 30 :1-11. Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients. Rado J, Janicak PG. Drugs Aging. 2012 2012 Oct 29(10):783-91. doi: 10.1007/s40266-012-0009-0. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. Depress Anxiety. 2012 2012 Jul 29(7):587-96. doi: 10.1002/da.21969. Epub 2012 Jun 11. Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy. Janicak PG, Rado JT. Expert Opin Pharmacother. 2012 2012 Aug 13(11):1645-52. doi: 10.1517/14656566.2012.681377. Epub 2012 May 3. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SM. J Clin Psychiatry. 2011 Sep 72(9):1263-9. Quetiapine monotherapy for bipolar depression. Janicak PG, Rado JT. Expert Opin Pharmacother. 2011 Jul 12(10):1643-51 Aripiprazole for late-life schizophrenia Rado J, Janicak PG Clin Interv Aging 2010 Sep 7 5:253-8 Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder Pavuluri MN, Henry DB, Findling RL, Parnes S, Carbray JA, Mohammed T, Janicak PG, Sweeney JA Bipolar Disord 2010 Sep 12(6):593-605. doi: 10 Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF Brain Stimul 2010 Oct 3(4):187-99 Transcranial magnetic stimulation for major depressive disorder: introduction Janicak PG Ann Clin Psychiatry 2010 Nov 22(4 Suppl 2):S3 Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial" O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA Biol Psychiatry 2010 Jan 15 67(2):e15-7 Iloperidone for schizophrenia Rado J, Janicak PG Expert Opin Pharmacother 2010 Aug 11(12):2087-93 The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S J Clin Psychiatry 2009 Jan 70(1):25-35 An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia Keedy SK, Rosen C, Khine T, Rajarethinam R, Janicak PG, Sweeney JA Psychiatry Res 2009 Apr 30 172(1):16-23 An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD Janicak PG CNS Spectr 2008 May 13(5):370-4 Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, Loo C, Thase ME, Demitrack MA, George MS J Clin Psychiatry 2008 Mar 69(3):441-51 Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials Janicak PG, Wu JH, Mao L Curr Med Res Opin 2008 Jun 24(6):1807-15 Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment Janicak PG, O'Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, Heart KL, Demitrack MA J Clin Psychiatry 2008 Feb 69(2):222-32
To watch a brief video of Philip G. Janicak, MD, click the play button at the lower left corner of the video frame below.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
We tend work with patients who have typically seen other psychiatrists, sometimes multiple psychiatrists, but haven’t been able to achieve sufficient improvement — mostly in the area of more severe mood disorders, major depression, bipolar disorder, what’s known as manic depression. Many of them can’t tolerate standard treatment approaches, and so we’ve been looking at alternative ways to improve their lives and to get their symptoms under control.
One that we’ve been focusing on now for about 14 years is something called transcranial magnetic stimulation, or TMS. It really offers an alternative that was not available to these patients before. These patients start going back to their homes and enjoying their life with their families. They increase their social contacts and activities. They go to work and find that they have more energy, more interest, are more productive. In many cases, these patients have dramatic benefits. I can tell stories about individuals, who were totally nonfunctional, able to go back to their professional lives for the first time in years as a result of the improvement that they experience with this treatment.